2-(3-chloropropyl)-6-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione

ID: ALA5286617

Max Phase: Preclinical

Molecular Formula: C15H11ClN2O4

Molecular Weight: 318.72

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1c2cccc3c([N+](=O)[O-])ccc(c23)C(=O)N1CCCCl

Standard InChI:  InChI=1S/C15H11ClN2O4/c16-7-2-8-17-14(19)10-4-1-3-9-12(18(21)22)6-5-11(13(9)10)15(17)20/h1,3-6H,2,7-8H2

Standard InChI Key:  LLJBMNWXSOWIFM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
    1.4280    0.8307    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7139    0.4175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0002    0.8276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0002    1.6538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7158    2.0669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7158    2.8930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4313    3.3062    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7168    0.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4310    0.8280    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7168   -0.4085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0018   -0.8222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7139   -0.4095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4338   -0.8238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4338   -1.6484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -2.0669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0018   -1.6509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7150   -2.0645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4345   -1.6546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4345   -0.8226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -2.8930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4345   -3.3062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0035   -3.3062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  3  8  1  0
  8  9  2  0
 10  8  1  0
 11 10  1  0
 11 12  1  0
 12  2  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 16 11  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 10 19  2  0
 20 15  1  0
 20 21  2  0
 20 22  1  0
M  CHG  2  20   1  22  -1
M  END

Alternative Forms

  1. Parent:

    ALA5286617

    ---

Associated Targets(Human)

HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 318.72Molecular Weight (Monoisotopic): 318.0407AlogP: 2.97#Rotatable Bonds: 4
Polar Surface Area: 80.52Molecular Species: HBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.57CX LogD: 2.57
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.38Np Likeness Score: -1.14

References

1. Tomczyk MD, Walczak KZ..  (2018)  l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.,  159  [PMID:30312931] [10.1016/j.ejmech.2018.09.055]

Source